Patent intelligence · US
US 11083635
Tampon delivery system for a pharmaceutical, holistic or medicinal component
Tampon delivery system for a pharmaceutical, holistic or medicinal component
Patent details — US 11083635
- Jurisdiction
- US
- Status
- granted
- Grant date
- Aug 10, 2021
- Expiration
- Aug 5, 2041
- Applicant
- Herphoric, Inc.
- Claims
- 25
- CPC classes
- A61K, A61K31/658, A61K9/0036
Quick answer
US 11083635 (Tampon delivery system for a pharmaceutical, holistic or medicinal component) is held by Herphoric, Inc.. Status: granted. Granted Aug 10, 2021. Expires Aug 5, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Herphoric, Inc.
- Grant date
- Expiration
- Claims
- 25
- CPC classes
- A61K, A61K31/658, A61K9/0036
More from Herphoric, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12312339
Polo like kinase 4 inhibitors
granted -
US 12239729
TRPV3 agonists for the treatment of skin conditions
granted -
US 12054556
Anti-PD-L1 antibody and use thereof
granted -
US 12018043
CD73 inhibitors
granted -
US 12005080
Method for promoting proliferation of immune cells
granted -
US 11993655
Anti-PD-L1 antibody and use thereof
granted -
US 11858915
Polo like kinase 4 inhibitors
granted -
US 11807658
CD73 inhibitors
granted
Frequently asked questions
What is US patent 11083635?
US 11083635 (Tampon delivery system for a pharmaceutical, holistic or medicinal component) is held by Herphoric, Inc.. Status: granted. Granted Aug 10, 2021. Expires Aug 5, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11083635?
Herphoric, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 52 pharmaceutical patents for this assignee.
When does US 11083635 expire?
Our index shows an expiration date of Aug 5, 2041 (15 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.